| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 04/21/1998 | US5741776 Method of administration of IGF-I |
| 04/21/1998 | US5741494 Immunopotentiative and infection-protective agent containing bacillus and egg white |
| 04/21/1998 | US5741492 Preparation and use of viral vectors for mixed envelope protein vaccines against human immunodeficiency viruses |
| 04/21/1998 | US5741488 Treatment of rheumatoid arthritis with anti-CD4 antibodies in conjunction with anti-TNF antibodies |
| 04/16/1998 | WO1998015624A1 Galectin 8, 9, 10 and 10sv |
| 04/16/1998 | WO1998015616A1 Methods for generating cytotoxic t cells in vitro |
| 04/16/1998 | WO1998015615A1 Method of producing a thymic microenvironment that supports the development of dendritic cells |
| 04/16/1998 | WO1998015579A1 Dendritic cell-specific antibodies |
| 04/16/1998 | WO1998015543A1 Aminothiazole derivatives, method of preparation and pharmaceutical compositions containing same |
| 04/16/1998 | WO1998015284A2 Mycosis vaccines |
| 04/16/1998 | WO1998009970A3 Alkylated rapamycin derivatives |
| 04/16/1998 | CA2269090A1 Methods for generating cytotoxic t cells in vitro |
| 04/16/1998 | CA2268284A1 Method of producing a thymic microenvironment that supports the development of dendritic cells |
| 04/16/1998 | CA2268022A1 Galectin 8, 9, 10 and 10sv |
| 04/16/1998 | CA2267154A1 Aminothiazole derivatives, method of preparation and pharmaceutical compositions containing same |
| 04/15/1998 | EP0835939A2 Fusion proteins with parts of immunoglobulins, their production and use |
| 04/15/1998 | EP0835928A1 Helicobacter pylori live vaccine |
| 04/15/1998 | EP0835312A2 Recombinant mistletoe lectin |
| 04/15/1998 | EP0835306A1 Recombinant antibodies from a phage display library, directed against a peptide-mhc complex |
| 04/15/1998 | EP0835266A1 Modified/chimeric superantigens and their use |
| 04/15/1998 | EP0835264A1 Human g-protein receptor hcegh45 |
| 04/15/1998 | EP0835263A2 Somatostatin peptides |
| 04/15/1998 | EP0835253A1 Piperidine and morpholine derivatives and their use as therapeutic agents |
| 04/15/1998 | EP0835133A1 Recombinant poxvirus-rabies compositions and combination compositions and uses |
| 04/15/1998 | EP0835125A1 Cd4-derived peptides that inhibit immune responses |
| 04/15/1998 | EP0666749B1 ENANTIOMERICALLY PURE beta-D-DIOXOLANE NUCLEOSIDES WITH SELECTIVE ANTI-HEPATITIS B VIRUS ACTIVITY |
| 04/15/1998 | CN1179106A Recombinant human alpha-fetoprotein and uses thereof |
| 04/15/1998 | CN1038035C Preparing method for polyethylene protein conjugates |
| 04/14/1998 | US5739338 Skin disorders, antiinflammatory agents, antitumor agents, vision defects, viricides, immunosuppressants |
| 04/14/1998 | US5739308 Forms a duplex with a target nucleic acid and then form triplex with duplex formed between oligonucleotide and target ncleic acid |
| 04/14/1998 | US5739300 Antiadhesive piperidine-and pyrrolidinecarboxylic acids |
| 04/14/1998 | US5739282 Amino acid sequence and dna |
| 04/14/1998 | US5739150 Piperidinyl thiacyclic derivatives |
| 04/14/1998 | US5739141 Antiproliferative substituted 5-thiapyrimidinone and 5-selenopyrimidinone compounds |
| 04/14/1998 | US5739138 Modulators of cellular response |
| 04/14/1998 | US5739130 Treating systemic lupus erythematosis, melanoma |
| 04/14/1998 | US5739118 Compositions and methods for delivery of genetic material |
| 04/14/1998 | US5739114 Immunosuppressive cyclolignan derivatives |
| 04/14/1998 | US5739105 Immunosuppressive agents |
| 04/14/1998 | US5739103 Mutants; antiinflammatory agents; anticholesterol agents; cardiovascular disorders; antiarthritic agents |
| 04/14/1998 | US5739032 Isolated nucleic acid encodes a glycoprotein for treating leukocyte adhesion deficiency |
| 04/14/1998 | US5738872 Antiallergens, antihistamines; bioavailability |
| 04/14/1998 | US5738848 Immunosuppressive compounds and method of preparing same |
| 04/14/1998 | CA2123367C Anti-allergic pharmaceutical composition for ophthalmic topical administration |
| 04/09/1998 | WO1998014598A1 INTERLEUKIN-1β CONVERTING ENZYME LIKE CYSTEINE PROTEASE |
| 04/09/1998 | WO1998014579A1 Rath genes and polypeptides and methods for the treatment and diagnosis of immune disorders |
| 04/09/1998 | WO1998014480A1 G protein-coupled receptor antagonists |
| 04/09/1998 | WO1998014473A1 Colostrinin, and uses thereof |
| 04/09/1998 | WO1998014464A1 Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof |
| 04/09/1998 | WO1998014463A1 MAGE-10 ENCODING cDNA, THE TUMOR REJECTION ANTIGEN PRECURSOR MAGE-10, ANTIBODIES SPECIFIC TO THE MOLECULE, AND USES THEREOF |
| 04/09/1998 | WO1998014446A1 Novel 3, 5, and/or 6 substituted analogues of swainsonine, processes for their preparation and their use as therapeutic agents |
| 04/09/1998 | WO1998014445A2 Novel 6 or 7 substituted analogues of swainsonine, processes for their preparation and their use as therapeutic agents |
| 04/09/1998 | WO1998014436A1 4,4-disubstituted-1,4-dihydro-2h-3,1-benzoxazin-2-ones useful as hiv reverse transcriptase inhibitors and intermediates and processes for making the same |
| 04/09/1998 | WO1998014432A1 Pde iv inhibiting 2-cyanoiminoimidazole derivatives |
| 04/09/1998 | WO1998014424A1 Hydroxamic acid derivatives |
| 04/09/1998 | WO1998014216A2 Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same |
| 04/09/1998 | WO1998014214A1 Methods for preventing, inhibiting or treating graft rejection reactions in graft-versus-host disease (gvhd) and organ transplantation |
| 04/09/1998 | WO1998014210A1 Method for treating allergic lung disease |
| 04/09/1998 | WO1998014203A1 A method and compositions for treatment of insulin-dependant diabetes mellitus |
| 04/09/1998 | WO1997045746A3 Prion protein binding proteins and uses thereof |
| 04/09/1998 | WO1997039721A3 Methods and compositions for regulating t cell subsets by modulating transcription factor activity |
| 04/09/1998 | DE19637518A1 PTX-sensitive G-Proteine, ihre Herstellung und Verwendung PTX-sensitive G-proteins, their production and use |
| 04/09/1998 | CA2645721A1 Human telomerase reverse transcriptase |
| 04/09/1998 | CA2269079A1 Rath genes and polypeptides and methods for the treatment and diagnosis of immune disorders |
| 04/09/1998 | CA2268953A1 4,4-disubstituted-1,4-dihydro-2h-3,1-benzoxazin-2-ones useful as hiv reverse transcriptase inhibitors and intermediates and processes for making the same |
| 04/09/1998 | CA2268114A1 Novel 6 or 7 substituted analogues of swainsonine, processes for their preparation and their use as therapeutic agents |
| 04/09/1998 | CA2267675A1 Method for treating allergic lung disease |
| 04/09/1998 | CA2267415A1 Hydroxamic acid derivatives |
| 04/09/1998 | CA2267412A1 Novel 3, 5, and/or 6 substituted analogues of swainsonine, processes for their preparation and their use as therapeutic agents |
| 04/09/1998 | CA2267202A1 Mage-10 encoding cdna, the tumor rejection antigen precursor mage-10, antibodies specific to the molecule, and uses thereof |
| 04/09/1998 | CA2267190A1 G protein-coupled receptor antagonists |
| 04/09/1998 | CA2267063A1 A method and compositions for treatment of insulin-dependant diabetes mellitus |
| 04/09/1998 | CA2236914A1 Interleukin-1.beta. converting enzyme like cysteine protease |
| 04/08/1998 | EP0834568A2 Novel saliva binding protein |
| 04/08/1998 | EP0834563A2 Human 7-transmembrane receptor, member of the chemokine receptor family, named Strl-33 |
| 04/08/1998 | EP0834510A2 Flavone derivative and medicine comprising the same |
| 04/08/1998 | EP0834508A1 Substituted biphenyl or phenylpyridine derivatives, process for their preparation and pharmaceutical compositions containing them |
| 04/08/1998 | EP0834507A1 Substituted diamino-1,3,5-triazine derivatives |
| 04/08/1998 | EP0834322A2 Mycosis vaccine |
| 04/08/1998 | EP0834315A1 Use of an imidazole derivative for the manufacture of a medicament for preventing and/or treating rhinitis |
| 04/08/1998 | EP0833933A1 A method for producing influenza hemagglutinin multivalent vaccines |
| 04/08/1998 | EP0833930A2 Fused soluble mhc heterodimer:peptide complexes and their uses |
| 04/08/1998 | EP0833916A1 Decorin binding protein compositions and methods of use |
| 04/08/1998 | EP0833914A1 Human chemokine beta-11 and human chemokine alpha-1 |
| 04/08/1998 | EP0833913A1 Antigen non-specific glycosylation inhibiting factor derivatives |
| 04/08/1998 | EP0833906A2 Novel ctla4/cd28 ligands and uses therefor |
| 04/08/1998 | EP0833842A1 Novel peptides for use in treatment of t-cell mediated cartilage destruction in autoimmune diseases |
| 04/08/1998 | EP0833828A1 Rapamycin derivatives |
| 04/08/1998 | EP0833818A1 Cb 2? receptor agonist compounds |
| 04/08/1998 | EP0833664A1 Combination of a cyclooxygenase-2 inhibitor and a leukotriene b 4? receptor antagonist for the treatment of inflammations |
| 04/08/1998 | EP0833656A2 Pharmaceutical compositions comprising restrictin p/activin a and use thereof as antagonist of il-6 and/or il-11 |
| 04/08/1998 | EP0833653A1 Serum immunoregulatory polypeptides and uses therefor |
| 04/08/1998 | EP0833650A1 P-selectin ligands and related molecules and methods |
| 04/08/1998 | EP0833649A1 Methods of preventing or treating allergies |
| 04/08/1998 | EP0833648A1 aPL IMMUNOREACTIVE PEPTIDES, CONJUGATES THEREOF AND METHODS OF TREATMENT FOR aPL ANTIBODY-MEDIATED PATHOLOGIES |
| 04/08/1998 | EP0833629A2 Aryl acrylic acid derivatives useful as protein tyrosine phosphatase inhibitors |
| 04/08/1998 | EP0833622A1 Compositions comprising a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor |
| 04/08/1998 | EP0680488B1 2,6-diaminopurine derivatives |
| 04/08/1998 | EP0558630B1 Retroviral protease inhibitors |
| 04/08/1998 | CN1178462A Methods and pharmaceutical compostions employing desmethylselegiline |